BE
Bloom Energy Corporation
BE has a slight edge over CAT overall, supported by stronger valuation.
CAT
Caterpillar Inc.
CAT has lower modeled downside risk, despite its lower overall score.
BE Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Healthy | |
| Strong |
BE's revenue, profitability, cash flow and balance sheet are all currently healthy.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
BE PE Valuation
BE has no meaningful PE right now: it lost money over the past year.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
BE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for BE, with profitability improving.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
BE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.75 | +4218% |
| Q2 2025 | $0.11 | +$1.38 |
| Q1 2025 | $0.02 | +$1.34 |
| Q4 2024 | -$0.13 | +$1.29 |
| Q3 2024 | -$0.53 | +$1.14 |
| Q2 2024 | -$1.27 | -$0.09 |
| Q1 2024 | -$1.32 | +$0.21 |
| Q4 2023 | -$1.42 | +$0.20 |
| Q3 2023 | -$1.67 | -$0.06 |
CAT has the stronger earnings trend. Trailing diluted EPS is down 91% for BE versus CAT up 31%.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $29.73 | +17% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
BE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +138% |
| Q2 2026 | $1.1B | +166% |
| Q1 2026 | $751.1M | +130% |
| Q4 2025 | $777.7M | +36% |
| Q3 2025 | $519M | +57% |
| Q2 2025 | $401.2M | +20% |
| Q1 2025 | $326M | +39% |
| Q4 2024 | $572.4M | +60% |
BE has the edge over CAT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 18% | +17 points |
| Q2 2026 | 17% | +18 points |
| Q1 2026 | 9.6% | +16 points |
| Q4 2025 | 11% | -7 points |
| Q3 2025 | 1.5% | +4.4 points |
| Q2 2025 | -0.9% | +6 points |
| Q1 2025 | -5.8% | +15 points |
| Q4 2024 | 18% | +15 points |
BE's operating margin was 18% last quarter, up 17 points from the same quarter a year ago, near the top of its range since 2019.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over BE on profitability, with a higher operating margin.
BE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$180.6M | -2552% |
| Q2 2026 | $174.8M | +$395.1M |
| Q1 2026 | $47.4M | +$172.4M |
| Q4 2025 | $395.1M | -16% |
| Q3 2025 | $7.4M | +$91.1M |
| Q2 2025 | -$220.4M | -$32.8M |
| Q1 2025 | -$124.9M | +$43.8M |
| Q4 2024 | $473.1M | +348% |
BE has the edge over CAT on cash flow, with more consistent year-over-year improvement.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
BE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +958K shares |
| 1 year | +38% | +89.4M shares |
| 3 years | +54% | +113M shares |
| 5 years | +86% | +150M shares |
| Available history | +182% | +209M shares |
BE has 324M diluted shares, up 38% from a year ago.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over BE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
BE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.0x | Net Cash |
| Q2 2026 | -0.5x | Net Cash |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.4x | Healthy |
| Q3 2025 | 3.8x | Elevated |
| Q2 2025 | 4.5x | High |
| Q1 2025 | 4.3x | High |
| Q4 2024 | 5.8x | High |
BE has more cash than debt.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over BE on leverage, with a lower net debt burden relative to earnings.
BE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.5 | Neutral |
| Stochastic | 24.9 | Neutral |
BE's weekly RSI is 46 (neutral) and its Stochastic is 25 (neutral).
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BE PE vs Industrials Sector
| Metric | BE | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
BE has no meaningful PE right now: it lost money over the past year.
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.1% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
BE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $231.4 | 13% below |
| 20 week MA | $231.4 | 13% below |
| 50 week MA | $202.4 | 0.2% below |
| 100 week MA | $123.2 | 64% above |
| 200 week MA | $68.9 | 193% above |
BE has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 193% above its 200-week average.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
BE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.37 | $30.5 | +379% |
| 2021 | $30.5 | $22.0 | -28% |
| 2022 | $22.0 | $18.5 | -16% |
| 2023 | $18.5 | $14.8 | -20% |
| 2024 | $14.8 | $22.9 | +55% |
| 2025 | $22.9 | $90.2 | +294% |
| 2026 YTD | $90.2 | $201.9 | +124% |
BE has the edge over CAT on returns for 2026, with the stronger performance.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.